These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17043926)

  • 1. Memantine fails to facilitate partial cigarette deprivation in smokers--no role of Memantine in the treatment of nicotine dependency?
    Thuerauf N; Lunkenheimer J; Lunkenheimer B; Sperling W; Bleich S; Schlabeck M; Wiltfang J; Kornhuber J
    J Neural Transm (Vienna); 2007 Mar; 114(3):351-7. PubMed ID: 17043926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
    Jones JD; Babalonis S; Marcus R; Vince B; Kelsh D; Lofwall MR; Fraser H; Paterson B; Martinez S; Martinez DM; Nunes EV; Walsh SL; Comer SD
    Addict Biol; 2020 Jul; 25(4):e12799. PubMed ID: 31240842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.
    Sofuoglu M; Herman AI; Li Y; Waters AJ
    Psychopharmacology (Berl); 2012 Dec; 224(3):413-20. PubMed ID: 22700039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial.
    Shiffman S; Ferguson SG; Strahs KR
    Am J Prev Med; 2009 Feb; 36(2):96-104.e1. PubMed ID: 19135903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study.
    McKee SA; Weinberger AH; Harrison EL; Coppola S; George TP
    Schizophr Res; 2009 Dec; 115(2-3):317-24. PubMed ID: 19700263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers.
    Demazières A; Luthringer R; Coppel E; Gilles C; Fleury C; Roegel JC; Delarue A; Laur C; Lagrue G
    Addict Behav; 2006 Mar; 31(3):537-43. PubMed ID: 15964703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial.
    Hamidovic A; Khafaja M; Brandon V; Anderson J; Ray G; Allan AM; Burge MR
    Mol Psychiatry; 2017 Oct; 22(10):1413-1421. PubMed ID: 28242873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B: Safety and subjective effects.
    Walele T; Sharma G; Savioz R; Martin C; Williams J
    Regul Toxicol Pharmacol; 2016 Feb; 74():193-9. PubMed ID: 26702788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
    Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
    Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
    Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W
    Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
    Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE
    J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of nicotine replacement therapy to treat nicotine withdrawal syndrome and aid temporary abstinence.
    Foulds J
    Int J Clin Pract; 2010 Feb; 64(3):292-4. PubMed ID: 20456168
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological, sensorimotor, and expectancy effects on tobacco withdrawal: a preliminary study.
    Guillot CR; Stone MD; Geary BA; Kirkpatrick MG; Tidey JW; Cook JW; Leventhal AM
    Hum Psychopharmacol; 2015 Sep; 30(5):364-71. PubMed ID: 26010521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bupropion. An antidepressant used to help smoking cessation].
    Taeron C
    Rev Infirm; 2002 May; (81):47-9. PubMed ID: 12078615
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.
    Weinberger AH; Sacco KA; Creeden CL; Vessicchio JC; Jatlow PI; George TP
    Schizophr Res; 2007 Mar; 91(1-3):217-25. PubMed ID: 17293085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study.
    Schmaal L; Berk L; Hulstijn KP; Cousijn J; Wiers RW; van den Brink W
    Eur Addict Res; 2011; 17(4):211-6. PubMed ID: 21606648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell.
    Paterson NE; Balfour DJ; Markou A
    Eur J Neurosci; 2007 May; 25(10):3099-108. PubMed ID: 17561823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.